Revisions ChromoGenics AB

Equities

CHRO

SE0020847481

Delayed Nasdaq Stockholm 12:00:00 2024-07-12 pm EDT 5-day change 1st Jan Change
9.98 SEK +0.81% Intraday chart for ChromoGenics AB +1.84% +42.57%

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CHRO Stock
  4. Revisions ChromoGenics AB